eCite Digital Repository

Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery

Citation

Shen, HH and Chan, EC and Lee, JH and Bee, YS and Lin, TW and Dusting, GJ and Liu, GS, Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery, Nanomedicine, 10, (13) pp. 2093-2107. ISSN 1743-5889 (2015) [Refereed Article]


Preview
PDF
2Mb
  

Copyright Statement

Guei-Sheung Liu & Hsin-Hui Shen. Licensed under the Creative Commons Attribution-NonCommercial 3.0 Unported License http://creativecommons.org/licenses/by-nc-nd/3.0/

DOI: doi:10.2217/nnm.15.47

Abstract

Pathologic neovascularization of the retina is a major cause of substantial and irreversible loss of vision. Drugs are difficult to deliver to the lesions in the back of the eye and this is a major obstacle for the therapeutics. Current pharmacological approach involves an intravitreal injection of anti-VEGF agents to prevent aberrant growth of blood vessels, but it has limitations including therapeutic efficacy and side-effects associated with systemic exposure and invasive surgery. Nanotechnology provides novel opportunities to overcome the limitations of conventional delivery system to reach the back of the eye through fabrication of nanostructures capable of encapsulating and delivering small molecules. This review article introduces various forms of nanocarrier that can be adopted by ocular drug delivery systems to improve current therapy. The application of nanotechnology in medicine brings new hope for ocular drug delivery in the back of the eye to manage the major causes of blindness associated with ocular neovascularization.

Item Details

Item Type:Refereed Article
Keywords:drug delivery, eye, nanocarriers, ocular neovascularization
Research Division:Technology
Research Group:Medical Biotechnology
Research Field:Gene and Molecular Therapy
Objective Division:Health
Objective Group:Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:Inherited Diseases (incl. Gene Therapy)
Author:Liu, GS (Dr Guei-Sheung Liu)
ID Code:120854
Year Published:2015
Web of Science® Times Cited:2
Deposited By:Menzies Institute for Medical Research
Deposited On:2017-08-31
Last Modified:2017-09-25
Downloads:12 View Download Statistics

Repository Staff Only: item control page